We tested and confirmed a significant increase in expression of HOXB13, AR, ORM1, KLK3, and NKX3-1 in PCa compared to symptomatic BPH in our validation studies with tissue specimens and cell line models. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.